Partners Group posted a blockbuster fundraising number for the first half of 2026, yet its stock continues to trade near multi-month lows — a disconnect that has left investors wrestling with the true health of the Swiss private-markets giant. The shares closed Friday at €743.20, still down 38.76% from the 52-week peak hit in August 2025 and 24% below the 200-day moving average of €978.30.
The headline figures certainly look strong. New capital commitments reached $16.0 billion in the six months to June 30, up from $12.2 billion in the same period a year earlier, while assets under management swelled to $186 billion. Management reaffirmed its full-year guidance of $26 billion to $32 billion in gross commitments. On the surface, that ought to be good news.
The trouble lies deeper in the income statement. Partners Group warned that performance fees — the richest-margin revenue stream for any private-markets manager — will account for less than 20% of total revenue in the first half, well below the target range of 25% to 40%. The company cited lower portfolio disposal activity and weaker overall portfolio performance as the culprits. For a firm that built its reputation on generating outsized returns for clients, that admission has dented confidence.
Evergreen products, the semi-liquid funds that have become a key growth engine, are adding to the strain. Redemption requests on the $8.6 billion Global Value SICAV hit 9.8% of net asset value in the second quarter, forcing Partners Group to cap withdrawals at the contractual limit of 5%. The outflow pressure has persisted, and management now expects net growth in 2026 and 2027 to be trimmed by one to two percentage points because of elevated redemptions from wealthy individual investors — a more fickle client base than the institutional investors that account for 80% of AuM.
Should investors sell immediately? Or is it worth buying Partners Group?
Not every piece of the portfolio is under pressure. The Private Markets Royalties strategy saw its AuM jump 50% to $1.5 billion in the first half, and the unit has closed eight transactions so far this year, including a secured loan tied to rights from South Park alongside Lyric Capital and Crayhill Capital Management. It remains a small slice of the overall business, but the growth trajectory offers a rare bright spot.
The broader market backdrop for private equity has not helped. A backlog of unsold portfolio companies continues to clog the exit pipeline, making it harder for firms to distribute gains back to investors. At the same time, a short seller in May accused Partners Group of overvaluing some of its Evergreen funds — a charge the company denied and responded to with a threat of legal action. That episode has amplified the trust question that now hangs over the stock.
On the positive side, the company has a 17-year streak of rising dividends, with a payout of 46.00 Swiss francs per share approved for 2025. The relative strength index sits at 45.8, indicating neither overbought nor oversold conditions, and the 52-week low of €686.80 is just 8% below the current price. A lower interest rate environment would ease liquidity in private markets and potentially unlock exits, giving Partners Group a tailwind.
The next hard data point arrives on September 1, 2026, when the full half-year report is due — including detailed figures on net flows, exit activity, and, crucially, whether performance fees can claw back toward their target range. Until then, the stock is caught between record fundraising and a growing list of warnings, with the market waiting to see which force wins out.
Ad
Partners Group Stock: Buy or Sell?! New Partners Group Analysis from July 18 delivers the answer:
The latest Partners Group figures speak for themselves: Urgent action needed for Partners Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 18.
Partners Group: Buy or sell? Read more here...









